Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesOptimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies
Immunotherapy, 11/05/09
Seiler T et al. – High response rates and durable remissions have been seen with both 90Y–ibritumomab tiuxetan and 131I–tositumomab. However, refractoriness to immunochemotherapy still remains a problem, especially in relapsed disease. Several novel targeted agents show encouraging activity in follicular lymphoma. This review will focus on current treatment strategies in this disease.
Related Articles
Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkins lymphoma: The Iowa Womens Health Study
International Journal of Cancer, 11/05/09
Relevance Score: 68%
Follicular lymphomas with plasmacytic differentiation include two subtypes
Modern Pathology, 10/22/09
Relevance Score: 68%
Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
British Journal of Haematology, 10/06/09
Relevance Score: 68%
Follicular lymphoma cells induce T-cell immunological synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy
Blood, 10/02/09
Relevance Score: 68%
Utility of the follicular lymphoma international prognostic index and the international prognostic index in assessing prognosis and predicting first-line treatment efficacy in follicular lymphoma patients
Acta Haematologica, 11/05/09
Relevance Score: 67%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia
Journal of Clinical Oncology, 12/20/09
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/20/09
High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)
Journal of Thrombosis and Haemostasis, 12/20/09
Sponsor
Article Search
Sponsor
Sponsor